“…In recent years, FPR and CPR have emerged as promising indicators capable of capturing both systemic inflammation and nutritional status in various diseases. This combined index of the FPR and CPR holds potential as a prognostic biomarker in patients with conditions such as tumors ( Matsunaga et al., 2020 ; Sun et al., 2020 ; Maruyama et al., 2022 ; Kwon et al., 2023 ), infectious diseases ( Yue et al., 2015 ; Bi et al., 2022 ), autoimmune diseases ( Cheng et al., 2021 ), and other ailments ( Zang et al., 2020 ; Yamada et al., 2021 ; Huang et al., 2022 ). To date, no studies have examined whether FPR and CPR can assess the prognosis of patients with SFTS.…”